Ratchaphruek Hospital PCLBKK:RPH-R 86 EBITDA Margin % is 21.55% as of Mar. 2026, which is 19% below its 10-year median of 26.66. GuruFocus rates BKK:RPH-R with a GF Score™ of 86/100 and a GF Value™ of ฿5.92. The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Ratchaphruek Hospital PCL ranks better than 85.63% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ratchaphruek Hospital PCL EBITDA Margin % Related Terms
Ratchaphruek Hospital PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:RPH-R vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Ratchaphruek Hospital PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ratchaphruek Hospital PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ratchaphruek Hospital PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ratchaphruek Hospital PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ratchaphruek Hospital PCL (BKK:RPH-R) has a EBITDA Margin % of 21.55% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ratchaphruek Hospital PCL and its competitors. This is 19% below median its historical median of 26.66. Over the past decade, Ratchaphruek Hospital PCL's EBITDA Margin % has ranged from 19.63 to 42.41. According to the industry distribution chart, Ratchaphruek Hospital PCL ranks #96 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 14.4%.
Is Ratchaphruek Hospital PCL's EBITDA Margin % too high?
Ratchaphruek Hospital PCL's current EBITDA Margin % of 21.55% is 19% below median its 10-year median of 26.66. Over the past 10 years, this metric has ranged from a low of 19.63 to a high of 42.41. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Ratchaphruek Hospital PCL's value of 21.55% is 111.1% above this industry median. Based on the distribution chart, Ratchaphruek Hospital PCL ranks #96 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ratchaphruek Hospital PCL has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Ratchaphruek Hospital PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ratchaphruek Hospital PCL ranks #96 out of 668 companies for EBITDA Margin %. This places Ratchaphruek Hospital PCL in the top 14% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Ratchaphruek Hospital PCL's value of 21.55% is 111.1% above this benchmark. Historically, Ratchaphruek Hospital PCL's own EBITDA Margin % has ranged from 19.63 to 42.41 over the past decade. While the company's 10-year median is 26.66 vs. the industry median of 10.21, Ratchaphruek Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ratchaphruek Hospital PCL's current EBITDA Margin % of 21.55% is 111.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ratchaphruek Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ratchaphruek Hospital PCL's current EBITDA Margin % is 21.55%, which is 19% below median its own 10-year median of 26.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ratchaphruek Hospital PCL stock overvalued right now?
Ratchaphruek Hospital PCL (BKK:RPH-R) has a current EBITDA Margin % of 21.55%. The stock's GF Value™ is ฿5.92, compared to a current price of ฿4.88 — trading 17.6% below its estimated fair value. The current EBITDA Margin % is 21.55%, which is 19% below median its 10-year median of 26.66 and 111.1% above the Healthcare Providers & Services industry median of 10.21. Ratchaphruek Hospital PCL's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ratchaphruek Hospital PCL (BKK:RPH-R), the current EBITDA Margin % is 21.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ratchaphruek Hospital PCL (BKK:RPH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Ratchaphruek Hospital PCL stock appears to be undervalued.
The current stock price of ฿4.88 is trading 17.6% below its estimated GF Value™ of ฿5.92.
Key valuation signals for BKK:RPH-R:
EBITDA Margin %: 21.55% (19% below median its 10-year median of 26.66)
GF Value™: ฿5.92 vs. price of ฿4.88 (17.6% below fair value)
Industry Position: 111.1% above the Healthcare Providers & Services median (#96 of 668)
No single metric tells the full story. See the BKK:RPH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ratchaphruek Hospital PCL is engaged in the hospital business. It provides medical services comprising in-patient department, which derives maximum revenue, and out-patient departments. Some of the services include Surgery, Pediatric, Orthopedic, Obstetrics and Gynecology, and others. The company also operates in a single geographic area, which is Thailand.
86GF Score
Get the complete analysis for BKK:RPH-R
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RPH-R has been successfully added to your 
